Citi opened a "Positive Catalyst Watch" on both Edwards Lifesciences (EW) and Zimmer Biomet (ZBH) into the Q1 prints and a "Negative Catalyst Watch on Medtronic (MDT). Most medical technology companies met expectations in Q4, which bodes well for Q1, the analyst tells investors in a research note. The firm says the sector has historically "worked" in a "beat and raise environment" and has historically been "recession resistant."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EW:
- Edwards Lifesciences initiated with a Neutral at UBS
- Wells downgrades Edwards Lifesciences with Medtronic gaining share
- Edwards Lifesciences downgraded to Equal Weight from Overweight at Wells Fargo
- Bernstein medical tech/devices analysts hold analyst/industry conference call
- Edwards Lifesciences downgraded to Market Perform from Outperform at Raymond James